Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

CorMedix Inc. - Common Stock (NQ:CRMD)

11.26 UNCHANGED
Streaming Delayed Price Updated: 4:00 PM EST, Jan 6, 2026 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about CorMedix Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
News headline image
CorMedix's DefenCath Aims to Tackle Catheter-Related Blood Stream Infections: Analyst ↗
RBC Capital Markets initiated coverage on CorMedix Inc (NASDAQ: CRMD) with an Outperform rating and a  
Via Benzinga
News headline image
Benzinga's Top Ratings Upgrades, Downgrades For August 10, 2023 ↗
 
Via Benzinga
News headline image
The Latest Analyst Ratings for Cormedix ↗
 
Via Benzinga
News headline image
CorMedix (CRMD) Q2 2023 Earnings Call Transcript ↗
CRMD earnings call for the period ending June 30, 2023. 
Via The Motley Fool
News headline image
Why Shares of CorMedix Are Slumping Thursday ↗
The company announced a stock sale and the sale of prefunded warrants. 
Via The Motley Fool
Analyst Ratings for Cormedix ↗
Analysts have provided the following ratings for Cormedix (NASDAQ:CRMD) within the last quarter: 
Via Benzinga
News headline image
What 5 Analyst Ratings Have To Say About Cormedix ↗
 
Via Benzinga
News headline image
CorMedix (CRMD) Q1 2023 Earnings Call Transcript ↗
CRMD earnings call for the period ending March 31, 2023. 
Via The Motley Fool
News headline image
Why Franklin Covey Shares Are Trading Higher By 25%? Here Are Other Stocks Moving In Thursday's Mid-Day Session ↗
Gainers Sigilon Therapeutics, Inc. (NASDAQ: SGTX) shares climbed 523.8% to $24.25 after Eli Lilly agreed to acquire the company for $14.92/share in cash. 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Intraday Session ↗
 
Via Benzinga
News headline image
Why Are Bank Stocks WFC, JPM, BAC Up Today? ↗
Banks stocks are heading higher on Thursday as investors react to the positive results of a stress test from the Federal Reserve. 
Via InvestorPlace
News headline image
Recap: Cormedix Q1 Earnings ↗
 
Via Benzinga
News headline image
Preview: Cormedix's Earnings ↗
 
Via Benzinga
News headline image
Expert Ratings for Cormedix ↗
 
Via Benzinga
News headline image
Cormedix's Return On Capital Employed Overview ↗
 
Via Benzinga
News headline image
FREY Stock Price Prediction: Is Freyr Battery Really Worth $13? ↗
Freyr Battery (FREY) stock is on the move Thursday with heavy trading following positive coverage from analysts at Morgan Stanley. 
Via InvestorPlace
News headline image
Why Is Cormedix (CRMD) Stock Down 23% Today? ↗
Cormedix (CRMD) stock is falling hard on Thursday with heavy trading after the company priced a public offering of its shares. 
Via InvestorPlace
News headline image
Why Cormedix (CRMD) Stock Is Getting Hammered ↗
CorMedix Inc. (NASDAQ: CRMD) shares are trading lower by 23.27% to $3.89 Thursday morning after the company priced its public offering of 7.5 million shares at $4 per share and pre-funded warrants to... 
Via Benzinga
News headline image
12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
 
Via Benzinga
News headline image
Why CorMedix Are Trading Lower By 22%; Here Are 20 Stocks Moving Premarket ↗
Gainers Eco Wave Power Global AB (NASDAQ: WAVE) shares surged 123% to $3.48 in pre-market trading after dropping over 8% on Wednesday. 
Via Benzinga
News headline image
A Preview Of Cormedix's Earnings ↗
 
Via Benzinga
Cormedix's Return On Capital Employed Insights ↗
 
Via Benzinga
News headline image
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday ↗
We're starting Thursday with a detailed look at all of the biggest pre-market stock movers worth keeping an eye on today! 
Via InvestorPlace
News headline image
As CorMedix's DefenCath Moves Forward On Regulatory Path, Analyst Boosts Price Target ↗
Tuesday, CorMedix Inc (NASDAQ: CRMD) resubmitted New Drug Application for DefenCath to the FDA, and the submission has been acknowledged as  
Via Benzinga
News headline image
Citius Pharmaceuticals Approaches End Of Trial For Catheter-Related Bloodstream Infections – How Are Analysts Scoring Its Stock? ↗
The late-stage biopharma Citius Pharmaceuticals Inc. (NASDAQ: CTXR) is approaching the conclusion of the phase 3 trial for its drug, Mino-Lok. 
Via Benzinga
News headline image
7 Small-Cap Biotech Stocks with Massive Potential ↗
Although small-cap biotech stocks present high risks, if they hit one out of the park, the rewards can be astronomical. 
Via InvestorPlace
News headline image
7 Biotech Stocks With Huge Return Potential for Long-Term Investors ↗
Although a wildly speculative sector, the low-cost, high-potential biotech stocks to buy and hold may deliver the goods for gamblers. 
Via InvestorPlace
News headline image
Hillstream BioPharma's Drug Candidate HSB-1216 Could Be One To Watch As Global Oncology Market Continues To Grow ↗
A surge in oncology drug development, coupled with increased patient access and early diagnosis, has resulted in a massive increase in global spending on cancer treatments. Due to this, the global... 
Via Benzinga
News headline image
CorMedix Inc Common Stock (CRMD) Q3 2022 Earnings Call Transcript ↗
CRMD earnings call for the period ending September 30, 2022. 
Via The Motley Fool
News headline image
CorMedix Inc. (NASDAQ:CRMD) Shareholder Alert: Investigation over Potential Wrongdoing ↗
San Diego, CA -- (SBWIRE) -- 11/04/2022 -- Certain directors of CorMedix Inc. are under investigation over potential breaches of fiduciary duties. 
Via SBWire
< Previous 1 2 3 4 5 6 7 8 9 10 11 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.